News
Our newsfeed is undergoing a system update. All stories will be repopulated soon!
-
Oral Menin-Based Triplet Shows Strong Early Activity in ND AML
The phase II SAVE trial presented at the 2025 American Society of…
-
FDA Approves Liso-Cel for R/R MZL
On December 4, 2025, the US Food and Drug Administration (FDA) approved…
-
FDA Approves Epcoritamab with Rituximab and Lenalidomide for R/R FL
On November 18, 2025, the US Food and Drug Administration approved epcoritamab-bysp…
Newsletter Coming Soon!
Beginning in 2026, we will be sending out a quarterly newsletter on key oncology insights and updates.